Meeting
2019 ASCO Annual Meeting
A comparison of adjuvant therapy approaches for patients with early-stage uterine serous carcinoma.
Authors
Katherine Kurnit
The University of Texas MD Anderson Cancer Center, Houston, TX
Katherine Kurnit , Silvana Pedra Nobre , Bryan M. Fellman , David A Iglesias , Kristina Lindemann , Ane Gerda Zahl Eriksson , Beyhan Atasevan , Gretchen Elizabeth Glaser , Jennifer Jean Mueller , Pamela T. Soliman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 5517)
DOI
10.1200/JCO.2019.37.15_suppl.5517
Abstract #
5517
Poster Bd #
340
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Omission of adjuvant chemotherapy in elderly patients with early stage breast cancer.
First Author: Sung Jun Ma
Poster
2015 ASCO Annual Meeting
The use of adjuvant treatment in stage I endometrioid endometrial cancer in the National Cancer Database (NCDB).
First Author: Angela Jain
Poster
2011 ASCO Annual Meeting
Paradigm shift in the management of high-intermediate risk stage I endometrial cancer.
First Author: J. O. Schorge
Poster
2023 ASCO Annual Meeting
The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations.
First Author: Jhanelle Elaine Gray